Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study

PURPOSE: Metastatic endocrine-resistant breast cancer (MBC) is a disease with poor prognosis and few treatment options. Low lymphocyte count is associated with limited overall survival. In a prospective cohort of lymphopenic patients with HER-2 negative MBC, we assessed the clinical and biological i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mery, Benoîte, Ménétrier-Caux, Christine, Montané, Laure, Heudel, Pierre-Etienne, Ray-Coquard, Isabelle, Bachelot, Thomas, Derbel, Olfa, Augereau, Paule, Treilleux, Isabelle, Berthet, Justine, Nkodia, Axelle, Bardin-Dit-Courageot, Christine, Attignon, Valery, Ferrari, Anthony, Garin, Gwenaele, Perol, David, Caux, Christophe, Dubois, Bertrand, Trédan, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150792/
https://www.ncbi.nlm.nih.gov/pubmed/37139242
http://dx.doi.org/10.2147/BCTT.S400055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150792/
https://www.ncbi.nlm.nih.gov/pubmed/37139242
http://dx.doi.org/10.2147/BCTT.S400055

Ejemplares similares